| Absorption |
| Blood-Brain Barrier | BBB- | 0.9653 |
| Human Intestinal Absorption | HIA- | 0.7665 |
| Caco-2 Permeability | Caco2- | 0.7105 |
| P-glycoprotein Substrate | Substrate | 0.7207 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8474 |
| Non-inhibitor | 0.9242 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8952 |
| Distribution |
| Subcellular localization | Mitochondria | 0.4673 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8266 |
| CYP450 2D6 Substrate | Non-substrate | 0.8194 |
| CYP450 3A4 Substrate | Substrate | 0.5407 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8789 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8229 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8915 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.6930 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.7290 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7876 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9993 |
| Non-inhibitor | 0.8466 |
| AMES Toxicity | Non AMES toxic | 0.8477 |
| Carcinogens | Non-carcinogens | 0.7180 |
| Fish Toxicity | High FHMT | 0.8865 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9247 |
| Honey Bee Toxicity | Low HBT | 0.7818 |
| Biodegradation | Not ready biodegradable | 0.9916 |
| Acute Oral Toxicity | III | 0.5356 |
| Carcinogenicity (Three-class) | Non-required | 0.6646 |